Customized Screening Protocols for Regional Needs
The Blood Screening Market is increasingly adapting to regional epidemiological profiles. For instance, areas with higher prevalence of malaria or Chagas disease may include these pathogens in standard screening panels, while others focus on different risks. MRFR values the market at USD 3.40 billion in 2024, anticipating growth to USD 5.60 billion by 2032. Tailoring protocols not only improves detection efficiency but also ensures cost-effectiveness by avoiding unnecessary tests. This trend is prompting manufacturers to design modular screening systems, allowing facilities to adjust pathogen panels based on local health data without replacing entire platforms. Such flexibility will be key to maintaining relevance in diverse global markets.